Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyosarcoma Uterus × Doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 165 Lymphoma, Large B-Cell, Diffuse 90 Lymphoma 90 Precursor Cell Lymphoblastic Leukemia-Lymphoma 72 Sarcoma 60 Hodgkin Disease 50 Lymphoma, Non-Hodgkin 35 Triple Negative Breast Neoplasms 33 Burkitt Lymphoma 33 Leukemia 31 Lymphoma, Mantle-Cell 30 Lymphoma, Follicular 28 Carcinoma, Hepatocellular 26 Multiple Myeloma 23 Ovarian Neoplasms 19 Neoplasms 18 Neoplasm Metastasis 18 Prostatic Neoplasms 17 Osteosarcoma 16 Lymphoma, Large-Cell, Anaplastic 16 Lymphoma, B-Cell 14 Neuroblastoma 13 Lymphoma, Large-Cell, Immunoblastic 13 Urinary Bladder Neoplasms 12 Lymphoma, T-Cell, Peripheral 12 Immunoblastic Lymphadenopathy 12 Inflammatory Breast Neoplasms 11 Stomach Neoplasms 10 Recurrence 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9

Interventions

Trabectedin 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06524583 2025-03-30

L-UteCIN

UNICANCER

Phase 2 Recruiting

Leiomyosarcoma Uterus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡